Will Amgen say “VESALIUS-CV”?
Amgen said “VESALIUS-CV” 1 time on its Nov 3, 2026 call (FY26 Q3), and on 7 of its last 8 calls: 1, 0, 1, 8, 2, 6, 3, 1 times. As of Nov 11, 2026, no Kalshi or Polymarket mention market on Amgen saying “VESALIUS-CV” has settled yet. Parrot’s p for the next listing is 79% (from the transcript model), not a forecast.
- Counts
- company speakers + operator
- Market
- 60¢ Kalshi (may be delayed)
Where it was said
quotes of at most 25 words; select an appearanceAmgen
VESALIUS-CV
- Probability
- 79% · n=0
- Last calls
- said in 7 of 8
Next listing counts: company speakers + operator
Counts: company speakers + operator (not listed here; the usual rule)
1 counted (1 in prepared remarks, 0 in Q&A).
…in both secondary prevention and high-risk primary prevention patients. With the landmark VESALIUS-CV results, Repatha is now the only PCSK9 inhibitor with phase III cardiovascular…
Counts: company speakers + operator (not listed here; the usual rule)
3 counted (3 in prepared remarks, 0 in Q&A).
…phase III outcomes data in both primary and secondary prevention. Our landmark VESALIUS-CV trial reinforces that earlier and more intensive LDL-C lowering before cardiovascular events…
…100,000 patient years of exposure. We continue to generate additional insights from VESALIUS-CV, the landmark study of Repatha in pre-event cardiovascular disease. We recently reported…
Counts: company speakers + operator (not listed here; the usual rule)
6 counted (5 in prepared remarks, 1 in Q&A).
…of therapy like Repatha. These guidelines do not yet reflect the practice-changing VESALIUS-CV data, leaving a clear opportunity to further evolve clinical guidelines and quality…
…risk in both primary and secondary prevention. Physician response to our landmark VESALIUS-CV study has been strong with sustained increases in new-to-brand prescribing across cardiology…
Questions
- How many times did Amgen say “VESALIUS-CV” on its last earnings call?
- Amgen said “VESALIUS-CV” 1 time on its Nov 3, 2026 call (FY26 Q3), and on 7 of its last 8 calls: 1, 0, 1, 8, 2, 6, 3, 1 times.
- Who has to say it for the market to count?
- Under the next market's rule: company speakers + operator.
Cite parrot.markets, “Amgen: ‘VESALIUS-CV’ mention history”, as of Nov 11, 2026, https://parrot.markets/earnings/AMGN/words/vesalius-cv (CC BY 4.0)
Agents: this page as TSV at /api/v1/word?entity=amgen&word=vesalius%20cv · quotes: /api/v1/quotes?entity=amgen&word=… · columnar JSON in #parrot-data · llms.txt · MCP